4
Changes in Ownership
Teladoc Health, Inc. Filed Acc 0001415889-22-002583
SVP - BUSINESS DEVELOPMENT sold 1,754 shares at $70.24 ($123,199)
- SVP - BUSINESS DEVELOPMENT acquired 5,785 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-02 | Option exercise | +1,205 | 8,761 | D | ||
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-02 | Option exercise | +2,050 | 10,811 | D | ||
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-02 | Option exercise | +515 | 11,326 | D | ||
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-02 | Option exercise | +1,147 | 12,473 | D | ||
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-02 | Option exercise | +868 | 13,341 | D | ||
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-03 | Sale | −1,754 | $70.24 | $123,199 | 11,587 | D |
| Derivatives | |||||||
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-02 | Option exercise · Restricted Stock Units | −1,205 | 1,205 | D | ||
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-02 | Option exercise · Performance Stock Units | −2,050 | 2,048 | D | ||
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-02 | Grant or award · Performance Stock Units | +1,030 | 1,030 | D | ||
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-02 | Option exercise · Performance Stock Units | −515 | 515 | D | ||
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-02 | Option exercise · Restricted Stock Units | −1,147 | 2,295 | D | ||
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-02 | Grant or award · Performance Stock Units | +2,602 | 2,602 | D | ||
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | 2022-03-02 | Option exercise · Performance Stock Units | −868 | 1,734 | D | ||
| Open-market sales · 1,754 sh · avg $70.24 · $123,199 | |||||||
Loading xslF345X03/form4-03042022_030324.xml…